NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 35 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 71,346,000 | $61,522 | 4.43% |
| BRAIDWELL LP | 135,834,000 | $118,012,579 | 3.73% |
| STEELHEAD PARTNERS LLC | 41,000,000 | $35,287,880 | 2.07% |
| DeepCurrents Investment Group LLC | 45,000,000 | $38,726,999 | 1.68% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 85,445,000 | $73,696,310 | 1.58% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,066,000 | $6,138,941 | 0.46% |
| LINDEN ADVISORS LP | 42,025,000 | $36,154,222 | 0.37% |
| Context Capital Management, LLC | 2,989 | $2,575 | 0.21% |
| Verition Fund Management LLC | 18,003 | $15,641,006 | 0.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,037,000 | $2,638,546 | 0.09% |